Thin ≤1 mm level III and IV melanomas are higher risk lesions for regional failure and warrant sentinel lymph node biopsy

Annals of Surgical Oncology

Volumn 7, Issue 6, 2000, Pages 456-460

  Corsetti, Ralph L ^a,b,d   Allen, Heidi M ^a   Wanebo, Harold J ^a,b,c  

^a ROGER WILLIAMS MEDICAL CENTER   (United States)

^b BROWN UNIVERSITY   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MidState Medical Center   (United States)

Author keywords

Clark level; Melanoma; Metastasis; Recurrence; Thin

Indexed keywords

ALPHA INTERFERON;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MORBIDITY; DISEASE FREE SURVIVAL; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR; TIME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TIME FACTORS;

EID: 0033623823     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-000-0456-4     Document Type: Article

References (20)

1. Reintgen D, Balch CM, Kirkwood J, et al. Recent advances in the care of the patient with malignant melanoma. Ann Surg 1997;225: 1-14.
2. Parker SL, Tong T, Bolden S, et al. Cancer statistics. CA Cancer J Clin 1996;46:5-28.
3. Clark WH Jr., Elder DE, Guerry D IV, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989;81:1893-904.
4. de Waal RM, van Altena MC, Erhard H, et al. Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination. Am J Path 1997;150: 1951-7.
5. Kirkwood JM, Strawderman MH, Ernstoff MS, et al. Adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996; 14:7-17.
6. Balch CM, Soong S-J, Bartolucci, AA. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996;224:255-66.
7. Morton DL, We DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-99.
8. Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radiolymphoscintigraphy improves sentinel node identification in patients with melanoma. Ann Surg 1996;223:217-24.
9. van der Spek-Keijser LM, van der Rhee HJ, Toth G, et al. Site, histological type, and thickness of primary cutaneous malignant melanoma in western Netherlands since 1980. Br J Dermatol 1997;136:565-71.
10. Veronesi U, Cascinelli N. Narrow excision (1-cm margin): A safe procedure for thin cutaneous melanoma. Arch Surg 1991;126:438-41.
11. Naruns PL, Nizze JA, Cochran AJ, et al. Recurrence potential of thin primary melanomas. Cancer 1986;57:545-48.
12. Tsao H, Cosimi AB, Sober AJ. Ultra-late recurrences (15 years or longer) of cutaneous melanoma. Cancer 1997;79:2361-70.
13. Balch CM, Song SJ, Shaw HM, et al. An analysis of prognostic factors and surgical results in 1786 patients with localized (stage I) melanoma treated in Alabama, USA and New South Wales, Australia. Ann Surg 1982;196:677-84.
14. Veronesi U, Cascinelli N, Adamus J, et al. Thin stage I primary cutaneous melanoma: Comparison of excision with margins of 1 to 3 cm. N Engl J Med 1988;318:1159-62.
15. Breslow A. In search of thin lethal melanoma (editorial). Surg Gynecol Obstet 1976;143:799.
16. Woods JE, Soule EH, Creagan ET. Metastasis and death in patients with thin melanomas (less than 0.76 mm). Ann Surg 1983;198: 63-4.
17. Shaw HM, McCarthy WH, McCarthy SW, et al. Thin malignant melanomas and recurrence potential. Arch Surg 1987;122:1147-50.
18. Kelly JW, Sagebiel RW, Clyman S, et al. Thin level IV malignant melanoma: a subset in which level is the major prognostic indicator. Ann Surg 1985;202:98-103.
19. Slingluff C, Vollmer R, Reintgen D, et al. Lethal thin malignant melanoma. Ann Surg 1988;208:150-61.
20. Day CL, Mihm MC, Sober AJ, et al. Prognostic factors for melanoma patients with lesions 0.76-1.69 mm in thickness. An appraisal of "thin" level IV lesions. Ann Surg 1982;195:30-4.